Roche's Parkinson's Drug Candidate Misses Key Goal in Mid-Stage Study

Roche's Parkinson's Drug Candidate Misses Key Goal in Mid-Stage Study

Roche's Parkinson's Drug Candidate Misses Key Goal in Mid-Stage Study


An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition.

Scroll to Top